Vasopressin release from the rat hypothalamo-neurohypophsial system: Effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists

Neuroendocrinology Letters

Volumn 26, Issue 4, 2005, Pages 367-372

  Juszczak, Marlena ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Neurokinin A; Substance P; Tachykinin receptors; Vasopressin

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ A; NEUROKININ A [4-10][5 TYROSINE 6,8,9 DEXTRO TRYPTOPHAN 10 LYSINE]; NEUROKININ A [4-10][8 BETA ALANINE]; SUBSTANCE P; SUBSTANCE P [6-11] DERIVATIVE; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST; VASOPRESSIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE INHIBITION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; ISOLATION PROCEDURE; MALE; NONHUMAN; PROTEIN FUNCTION; RAT; VASOPRESSIN RELEASE;

EID: 27244457948     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Dam TV, Escher E, Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res 1988; 453:372-6.
2. Guartara L, Maggi CA. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 1988; 32:1-49.
3. Hagan RM, Beresford IJM, Stables J, Dupere J, Stubbs C, Elliot P et al. Characterization, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Reg Pept 1993; 46:9-19.
4. Maggio J. Tachykinins. Ann Rev Neurosci 1988; 11:13-28.
5. Torrens Y, Beaujouan J-C, Dietl M, Saffroy M, Petitet F, Glowinski J. Tachykinin receptors: binding and cellular activity assays. Methods Neurosci 1991; 5:243-67.
6. Harlan RE, Garcia MM, Krause JE. Cellular localization of substance P- and neurokinin A-encoding preprotachykinin mRNA in the female rat brain. J Comp Neurol 1989; 287:179-212.
7. Nevin K, Zhuo H, Helke CJ. Neurokinin A coexists with substance P and serotonin in ventral medullary spinally projecting neurons of the rat. Peptides 1994; 15:1003-11.
8. Bittencourt JC, Benoit R, Sawchenko PE. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections. J Chem Neuroanat 1991; 4:63-78.
9. Larsen PJ, Jessop DS, Lightman SL, Chowdrey HS. Preprotachykinin A gene expression in distinct hypothalamic and brain stem regions of the rat is affected by a chronic osmotic stimulus: a combined immunohistochemical and in situ hybridization histochemistry study. Brain Res Bull 1993; 30:535-45.
10. Mikkelsen JD, Schmidt P, Sheikh, SP, Larsen PJ. Non-vasopressinergic, non-oxytocinergic neuropeptides in the rat hypothalamoneurohypophyseal tract: experimental immunohistochemical studies. Prog Brain Res 1992; 91:367-71.
11. Mikkelsen JD, Larsen PJ, Møller M, Vilhardt H, Særmark T. Substance P in the median eminence and pituitary of the rat: demonstration of immunoreactive fibres and specific binding sites. Neuroendocrinology 1989; 50:100-8.
12. Juszczak M, Guzek JW, Lewy A. The influence of melatonin on the content of vasopressin and oxytocin in the hypothalamus and neurohypophysis in euhydrated and dehydrated male rats. J Pineal Res 1986; 3:99-211.
13. Juszczak M, Debeljuk L, Stempniak B, Steger RW, Fadden C, Bartke A. Neurohypophyseal vasopressin in the Syrian hamster: response to short photoperiod, pinealectomy, melatonin treatment or osmotic stimulation. Brain Res Bull 1997; 42:221-5.
14. Juszczak M, Bojanowska E, Guzek JW, Stempniak B, Dabrowski R. The effect of melatonin on vasopressin release under stress conditions in pinealectomized male rats. Adv Exp Med Biol 1999; 460:311-5.
15. Chowdrey HS, Lightman SL. Role of central amino acids and peptide-mediated pathways in neurohypophysial hormone release. Ann NY Acad Sci 1993; 689:183-93.
16. Sladek CD, Kapoor JR. Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. Experimental Neurology 2001; 171:200-9.
17. Jessop DS, Chowdrey HS, Lightman SL. Substance P and substance K in the median eminence and paraventricular nucleus of the rat hypothalamus. Neuropeptides 1990;17:135-40.
18. Larsen PJ, Jessop DS, Chowdrey HS, Mikkelsen JD, Lightman SL. Osmotic regulation of substance P and neurokinin A peptide content and substance P binding sites in distinct hypothalamic nuclei of the rat. Peptides 1992; 13:705-12.
19. Duval P, Lenoir V, Moussaoui S, Garret C, Kerdelhue B. Substance P and neurokinin A variations throughout the rat oestrous cycle; comparison with ovariectomized and male rats: I. Plasma, hypothalamus, anterior and posterior pituitary. J Neurosci Res 1996; 45:598-609.
20. Massi M, Saija A, Polidori C, Perfumi, M, Enttili L, Costa G, et al. The hypothalamic paraventricular nucleus is a site of action for the central effect of tachykinin on plasma vasopressin. Brain Res Bull 1991; 26:149-54.
21. Clarke G, Kirby PJC, Thomson AM. Effect on vasopressinergic and oxytocinergic neurones of intraventricular substance P. J Physiol (London) 1980; 307:59P.
22. Massi M, Polidori C, Perfumi M, Gentili L, De Caro G. Tachykinin receptor subtypes involved in the central effects of tachykinins on water and salt intake. Brain Res Bull 1991; 26:155-60.
23. Chiodera P, Coiro V. Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men. Brain Research 1992; 569:173-6.
24. Chowdrey HS, Jessop DS, Lightman SL. Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat. Neuroendocrinology 1990; 52:90-3.
25. Kapoor JR, Sladek CD. Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am J Physiol 2001; 280:R69-78.
26. Juszczak M. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies. J Physiol Pharmacol 2002; 53:823-34.
27. Juszczak M, Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Brain Res Bull 2003; 59:393-7.
28. Sakurada T, Manome Y, Tan-No K, Sakurada S, Kisara K, Ohba M, et al. A selective and extremely potent antagonist of the neurokinin-1 receptor. Brain Res 1992; 593:319-22.
29. Maggi CA, Giuliani S, Ballati L, Lecci A, Manzini S, Patacchini R, et al. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther 1991; 257:1172-8.
30. Maggi CA, Patacchini R, Meini S, Quartara L, Sisto A, Potier E, et al. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol 1994; 112:150-60.